T. Levin

T. Levin, Jeffrey-K Lee, Angela Lam, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Screening in liver disease: Report of an AASLD clinical workshop

T. Levin, D. Provenzale, M. Arthur, 2004, Hepatology.

Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.

R. Wolff, T. Levin, M. Slattery, 2005, Cancer research.

Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time.

T. Levin, M. Slattery, A. Kinney, 2004, Preventive medicine.

Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study

M. Alter, T. Levin, E. Murphy, 2013, Hepatology.

Automated phone and mail population outreach to promote colorectal cancer screening.

T. Levin, E. France, S. Shetterly, 2012, The American journal of managed care.

Multitarget stool DNA testing for colorectal-cancer screening.

D. Ransohoff, P. Lavin, D. Ahlquist, 2014, The New England journal of medicine.

In simulation modelling, there are multiple ways to effectively screen for colorectal cancer

T. Levin, 2017, Evidence-Based Medicine.

Colorectal cancer screening: 80% by 2018. Colonoscopists simply cannot do it alone.

T. Levin, 2016, Gastrointestinal endoscopy.

Dealing With Uncertainty: Surveillance Colonoscopy After Polypectomy

T. Levin, 2007, The American Journal of Gastroenterology.

Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored summit.

Alison R. T. Brenner, T. Levin, G. Coronado, 2020, CA: a cancer journal for clinicians.

Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2017, Gastrointestinal endoscopy.

Colorectal Cancer Screening: Money Isn't Everything . . . But It Helps!

T. Levin, 2017, Gastroenterology.

Heterogeneity in colorectal cancer incidence among people recommended 3-yearly surveillance post-polypectomy: a validation study

T. Levin, A. Cross, C. Nickerson, 2020, Endoscopy.

CONTRIBUTIONS CYP 1 A 1 , Cigarette Smoking , and Colon and Rectal Cancer

S. Neuhausen, T. Levin, M. Slattery, 2004 .

Lack of Association Between Insulin Sensitivity and Colorectal Adenoma Risk

T. Byers, S. Haffner, D. Ahnen, 2010, Nutrition and cancer.

Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi‐Society Task Force on Colorectal Cancer and the American Cancer Society * , †

Robert H Fletcher, Tim Byers, Randall W Burt, 2006, Gastroenterology.

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.

Robert H Fletcher, Tim Byers, Randall W Burt, 2006, CA: a cancer journal for clinicians.

Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy.

L. Ackerson, J. Selby, T. Levin, 1999, JAMA.

Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018

A. Jemal, A. Zauber, Chyke A Doubeni, 2015, Cancer.

Adenoma detection rate and risk of colorectal cancer and death.

Chyke A Doubeni, T. Levin, D. Corley, 2014, The New England journal of medicine.

Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population

Christopher D. Jensen, E. Halm, T. Levin, 2022, Gastroenterology.

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * †

Perry J Pickhardt, Douglas K Rex, Sidney J Winawer, 2008, CA: a cancer journal for clinicians.

What does sigmoidoscopy really miss?

T. Levin, 2003, American Journal of Gastroenterology.

Current and future colorectal cancer screening strategies

T. Levin, A. Shaukat, 2022, Nature Reviews Gastroenterology & Hepatology.

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era

E. Kuipers, C. Hassan, M. Kaminski, 2020, Gastroenterology.

Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry.

V. Weinberg, T. Levin, J. Gum, 2002, Gastroenterology.

Risk stratification for colorectal cancer in individuals with subtypes of serrated polyps

T. Levin, L. Herrinton, D. Corley, 2021, Gut.

What does sigmoidoscopy really miss?: Lewis JD, Kimmie NG, Hung KE, et al., Detection of proximal adenomatous polyps with screening sigmoidoscopy—a systematic review and meta-analysis of screening colonoscopy, Arch Intern Med 2003;163:413–20

T. Levin, 2003 .

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

Randall W Burt, Douglas K Rex, Tonya Kaltenbach, 2014, Gastroenterology.

Abstract 4163: Higher Dose Exposure of Lovastatin is Not Associated with Adverse Hepatic Outcomes in Patients with Existing Liver Disease

L. Ackerson, M. Manos, T. Levin, 2006 .

Change in Body Size and the Risk of Colorectal Adenomas

T. Byers, S. Haffner, T. Levin, 2007, Cancer Epidemiology Biomarkers & Prevention.

Are Patients With Elevated Liver Tests at Increased Risk of Drug-Induced Liver Injury?

N. Marcon, L. Ackerson, R. Sandler, 2004 .

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

Randall W Burt, Douglas K Rex, Tonya Kaltenbach, 2014, Diseases of the colon and rectum.

1023 Impact of Variation in Screening Colonoscopy Quality on the Prevention of Colorectal Cancer Deaths. A Modelling Study

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2013 .

Complications of Colonoscopy in an Integrated Health Care Delivery System

J. Schulman, L. Seeff, T. Levin, 2006, Annals of Internal Medicine.

Gastric and duodenal safety of daily alendronate.

A. LaCroix, J. Gurwitz, J. Chandler, 2002, Archives of internal medicine.

Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study

Michael Goodman, Robert H Fletcher, Shivan J Mehta, 2016, Gut.

Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.

U. Ladabaum, T. Levin, P. Bacchetti, 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Iron Intake and Body Iron Stores as Risk Factors for Barrett's Esophagus: A Community-Based Study

G. Block, T. Levin, L. Habel, 2008, The American Journal of Gastroenterology.

Dietary Antioxidants, Fruits, and Vegetables and the Risk of Barrett's Esophagus

G. Block, T. Levin, D. Corley, 2008, The American Journal of Gastroenterology.

Hemochromatosis Gene Status as a Risk Factor for Barrett’s Esophagus

G. Block, T. Levin, L. Habel, 2008, Digestive Diseases and Sciences.

Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia.

L. Kann, S. Markowitz, D. Ahlquist, 2006, Clinical chemistry.

The evolution to stool DNA testing for colorectal cancer

T. Levin, M. Lawson, K. Tagore, 2004, Alimentary pharmacology & therapeutics.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

D. Lieberman, D. Rex, T. Levin, 2017, Gastroenterology.

Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

G. Block, T. Levin, L. Habel, 2007, Gastroenterology.

Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting.

Christopher D. Jensen, S. Kakar, T. Levin, 2017, Gastrointestinal endoscopy.

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-society Task Force on Colorectal Cancer.

D. Lieberman, D. Rex, T. Levin, 2017, Journal of pediatric gastroenterology and nutrition.

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

D. Lieberman, D. Rex, T. Levin, 2017, Gastroenterology.

Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.

T. Levin, J. Lewis, L. Herrinton, 2012, Gastroenterology.

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

D. Lieberman, D. Rex, T. Levin, 2017, The American Journal of Gastroenterology.

Family history and colorectal cancer: predictors of risk

T. Levin, R. Holubkov, M. Slattery, 2003, Cancer Causes & Control.

Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs.

Bruce H Fireman, Christopher D. Jensen, Chyke A Doubeni, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia

D. Sargent, S. Hillman, D. Ahlquist, 2008, Annals of Internal Medicine.

Accuracy of Fecal Immunochemical Tests for Colorectal Cancer

T. Levin, D. Corley, Jeffrey-K Lee, 2014, Annals of Internal Medicine.

Helicobacter pylori and Gastroesophageal Reflux Disease: A Case–Control Study

G. Block, T. Levin, L. Habel, 2008, Helicobacter.

Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study

G. Block, T. Levin, L. Habel, 2007, Gut.

Surveillance and survival in Barrett's adenocarcinomas: a population-based study.

Noel S Weiss, T. Levin, N. Weiss, 2002, Gastroenterology.

Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus.

G. Block, T. Levin, D. Corley, 2009, Gastroenterology.

Cigarette smoking and the risk of Barrett’s esophagus

G. Block, T. Levin, D. Corley, 2009, Cancer Causes & Control.

Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994–2006

G. Block, T. Levin, L. Habel, 2008, Gut.

Dietary patterns and the risk of Barrett's esophagus.

G. Block, T. Levin, D. Corley, 2008, American journal of epidemiology.

Validation of an Algorithm to Identify Patients at Risk for Colorectal Cancer Based on Laboratory Test and Demographic Data in Diverse, Community-Based Population.

T. Levin, D. Corley, J. Schneider, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2016, The Journal of the American Board of Family Medicine.

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer.

J. Church, D. Lieberman, D. Rex, 2014, Gastrointestinal endoscopy.

Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer.

A. Barkun, D. Lieberman, D. Rex, 2014, Gastroenterology.

Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer.

A. Barkun, D. Lieberman, D. Rex, 2014, Gastrointestinal endoscopy.

Optimizing Adequacy of Bowel Cleansing for Colonoscopy: Recommendations From the US Multi-Society Task Force on Colorectal Cancer

Douglas K Rex, Tonya Kaltenbach, A. Barkun, 2014, The American Journal of Gastroenterology.

Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.

C. Ulrich, R. Wolff, J. Potter, 2007, Carcinogenesis.

Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus Update by the American Cancer Society and US Multi‐Society Task Force on Colorectal Cancer * †

Charles J. Kahi, T. Byers, N. Hyman, 2006, CA: a cancer journal for clinicians.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

J. P. Tucker, D. Ransohoff, J. Selby, 2007, Journal of the National Cancer Institute.

Colorectal cancer deaths attributable to nonuse of screening in the United States.

A. Zauber, Chyke A Doubeni, I. Lansdorp-Vogelaar, 2015, Annals of epidemiology.

Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

J. Church, D. Lieberman, D. Rex, 2014, The American Journal of Gastroenterology.

Organized colorectal cancer screening in integrated health care systems.

T. Levin, Michael Oehrli, L. Jamieson, 2011, Epidemiologic reviews.

Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer

R. Wolff, J. Potter, T. Levin, 2007, International journal of cancer.

Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.

S. Neuhausen, T. Levin, M. Slattery, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer

David Lieberman, Douglas K Rex, Tonya Kaltenbach, 2017, The American Journal of Gastroenterology.

Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer.

David Lieberman, Douglas K Rex, Tonya Kaltenbach, 2017, Gastrointestinal endoscopy.

Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma

T. Byers, S. Haffner, D. Ahnen, 2015, BMC Cancer.

Organic mood disorder associated with the HAIR-AN syndrome.

T. Levin, A. Stoudemire, T. Terrell, 1992, The Journal of neuropsychiatry and clinical neurosciences.

Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization.

Gurkirpal Singh, Uri Ladabaum, U. Ladabaum, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer.

D. Lieberman, D. Rex, T. Levin, 2017, Gastrointestinal endoscopy.

Hepatic Effects of Lovastatin Exposure in Patients with Liver Disease

L. Ackerson, M. Manos, T. Levin, 2008, Drug safety.

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection

T. Levin, D. Corley, K. Selby, 2019, Annals of Internal Medicine.

Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis

A. Zauber, C. Rutter, I. Lansdorp-Vogelaar, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

D. Lieberman, D. Rex, T. Levin, 2017, The American Journal of Gastroenterology.

Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2019, Gastrointestinal endoscopy.

Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.

Christopher D. Jensen, E. Halm, A. Zauber, 2020, Gastroenterology.

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

E. Halm, Chyke A Doubeni, C. Rutter, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Associations between apoE genotype and colon and rectal cancer.

R. Wolff, J. Potter, T. Levin, 2005, Carcinogenesis.

Strategies to Curb the Increasing Burden of Early Onset Colorectal Cancer

Swati G. Patel, T. Levin, T. Yen, 2023, Techniques and Innovations in Gastrointestinal Endoscopy.

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Uri Ladabaum, U. Ladabaum, T. Levin, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

What Is Organized Screening and What Is Its Value?

T. Levin, J. Dominitz, 2020, Gastrointestinal endoscopy clinics of North America.

Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme

T. Levin, N. Weiss, V. P. Doria-Rose, 2014, Gut.

Colonoscopy capacity: Can we build it? Will they come?

T. Levin, Theodore R Levin, 2004, Gastroenterology.

Aarnio M, Mecklin JP, Aaltonen LA, Nyström-Lahti M, Järvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995 64(6):430-3. PMID: 8550246

S. Woolf, R. Fletcher, T. Ganiats, 2011 .

Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program.

Christopher D. Jensen, A. Jemal, Chyke A Doubeni, 2017, American journal of preventive medicine.

Complications of screening flexible sigmoidoscopy.

J. Selby, T. Levin, J. Shapiro, 2002, Gastroenterology.

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer.

Charles J. Kahi, T. Byers, N. Hyman, 2006, Gastroenterology.

Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.

D. Lieberman, D. Rex, T. Levin, 2017, Gastrointestinal endoscopy.

Update by the US Multi-Society Task Force on Colorectal Cancer and the Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus

A. Zauber, T. Byers, N. Hyman, 2006 .

Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2016, Gastrointestinal endoscopy.

Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2019, JAMA internal medicine.

Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer

Charles J. Kahi, D. Lieberman, D. Rex, 2016, The American Journal of Gastroenterology.

Screening Colonoscopy and Risk for Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults

Chyke A Doubeni, R. Fletcher, C. Rutter, 2013, Annals of Internal Medicine.

Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable.

Robert Fletcher, David Lieberman, Robert Schoen, 2007, Gastrointestinal endoscopy.

Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.

Shivan J. Mehta, Christopher D. Jensen, A. Zauber, 2019, Gastroenterology.

Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2018, Gastroenterology.

The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer?

T. Levin, D. Corley, Jeffrey-K Lee, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Colonoscopy surveillance after colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer.

Charles J. Kahi, D. Lieberman, D. Rex, 2016, Gastrointestinal endoscopy.

Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.

Charles J. Kahi, D. Lieberman, D. Rex, 2016, Gastroenterology.

Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.

Karen Curtin, Martha L Slattery, R. Wolff, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Validation of diagnoses of peptic ulcers and bleeding from administrative databases: a multi-health maintenance organization study.

A. LaCroix, J. Gurwitz, R. Platt, 2002, Journal of clinical epidemiology.

A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening

A. Zauber, T. Church, D. Lieberman, 2017, The American Journal of Gastroenterology.

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2016, Annals of Internal Medicine.

Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2015, JAMA.

Variation in AdenomaDetection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening AMicrosimulationModel

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2015 .

Implications of New Colorectal Cancer Screening Technologies for Primary Care Practice

D. Ransohoff, A. Zauber, C. Jaffe, 2008, Medical care.

Does family history still matter in the era of screening colonoscopy?

T. Levin, 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Flexible sigmoidoscopy for colorectal cancer screening: valid approach or short-sighted?

T. Levin, 2002, Gastroenterology clinics of North America.

Flexible sigmoidoscopy: an important screening option for average-risk individuals.

T. Levin, A. Palitz, Albert M. Palitz, 2002, Gastrointestinal endoscopy clinics of North America.

Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial.

L. Ackerson, L. Green, T. Levin, 2013, American journal of public health.

Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group

G. Hoff, D. Rex, T. Levin, 2005, Gut.

Quality Of Life Measurement Clarifies The Cost-Effectiveness Of Helicobacter Pylori Eradication In Peptic Ulcer Disease And Uninvestigated Dyspepsia

T. Lieu, A. Fendrick, L. Ackerson, 2001, American Journal of Gastroenterology.

A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization

J. Selby, T. Levin, J. Henning, 1998, American Journal of Gastroenterology.

Disparities in Preventable Mortality from Colorectal Cancer: are they the result of structural racism?

Chyke A Doubeni, T. Levin, K. Selby, 2021, Gastroenterology.

Serial Glycosylated Hemoglobin Levels and Risk of Colorectal Neoplasia among Patients with Type 2 Diabetes Mellitus

A. Ferrara, T. Levin, L. Habel, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Association between Improved Colorectal Screening and Racial Disparities.

Christopher D. Jensen, Chyke A Doubeni, T. Levin, 2022, The New England journal of medicine.

Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study

Christopher D. Jensen, T. Levin, P. Bacchetti, 2019, Clinical and translational gastroenterology.

Medical therapy for diabetes is associated with increased use of lower endoscopy

A. Ferrara, T. Levin, L. Habel, 2007, Pharmacoepidemiology and drug safety.

Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux

T. Levin, K. Mcquaid, R. Sperling, 1998, American Journal of Gastroenterology.

The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval.

J. Selby, P. Newcomb, T. Levin, 2004, Gastroenterology.

The importance of choosing colorectal cancer screening tests: comment on "Adherence to colorectal cancer screening".

T. Levin, 2012, Archives of internal medicine.

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a Health Maintenance Organization

T. Levin, J. Henning, C. Henke, 2000, American Journal of Gastroenterology.

Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-based Colorectal Cancer Screening Program.

Molly A. E. Landau, Christopher D. Jensen, T. Levin, 2020, Gastroenterology.

Colorectal cancer screening in the COVID-19 era

E. Kuipers, C. Hassan, M. Kaminski, 2020, Gastroenterology.

Colorectal Cancer Update by the American Cancer Society and US Multi-Society Task Force on Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus

T. Byers, N. Hyman, R. Fletcher, 2008 .

uidelines for Colonoscopy Surveillance After Cancer esection : A Consensus Update by the American ancer Society and the US Multi-Society Task orce on Colorectal Cancer

Charles J. Kahi, T. Byers, N. Hyman, 2006 .

The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium

Yingye Zheng, Karen J Wernli, Jasmin A Tiro, 2014, Cancer Epidemiology, Biomarkers & Prevention.

969 Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018

A. Jemal, A. Zauber, Chyke A Doubeni, 2015 .

Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps.

T. Levin, L. Herrinton, D. Corley, 2020, Gastroenterology.

A Practical Approach for Colorectal Cancer Screening

Dan, T. Levin, M. Schapiro, 2016 .

Editorial: It's Time to Make Organized Colorectal Cancer Screening Convenient and Easy for Patients

T. Levin, 2009, The American Journal of Gastroenterology.

Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study

N. Perrin, T. Levin, David H. Smith, 2018, BMC Cancer.

Development and validation of an algorithm for classifying colonoscopy indication.

Christopher D. Jensen, A. Zauber, Chyke A Doubeni, 2015, Gastrointestinal endoscopy.

Cimetidine Use and Risk of Breast, Prostate, and Other Cancers

T. Levin, G. Friedman, L. Habel, 2000, Pharmacoepidemiology and drug safety.

Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial.

L. Ackerson, L. Green, T. Levin, 2013, American Journal of Public Health.

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles

C. O'Morain, D. Ransohoff, P. Bossuyt, 2023, Gut.

Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing

Christopher D. Jensen, Chyke A Doubeni, T. Levin, 2020, Clinical Gastroenterology and Hepatology.

A challenging presentation of left upper quadrant pain

P. Newcomb, T. Levin, V. P. Doria-Rose, 2005, Gut.

Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old.

E. Halm, T. Levin, D. Corley, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Esophageal metaplasia to adenocarcinoma: A population-based natural history

T. Levin, L. Habel, D. Corley, 2003 .

Reducing unnecessary surveillance colonoscopies: a mandate for endoscopists.

T. Levin, Theodore R Levin, 2006, Gastrointestinal endoscopy.

Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test.

Chyke A Doubeni, T. Levin, D. Corley, 2017, JAMA.

Association between surveillance and survival in Barrett's adenocarcinomas: A population-based study

T. Levin, D. Corley, P. Buffler, 2001 .

Re: Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study.

T. Levin, R. Schoen, 2003, Journal of the National Cancer Institute.

Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.

T. Levin, J. Lewis, L. Herrinton, 2012, Gastroenterology.